HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Case Reports
Case Reports
- Rare and Challenging Cases: Presentations of rare cancers and unusual clinical presentations.
- Innovative Treatments: Case studies of novel therapeutic approaches.
- Multi-disciplinary Case Management: Integrative approaches involving multiple specialties.
- Long-Term Survivorship Cases: Experiences and outcomes of long-term cancer survivors.
- Adverse Events and Complications: Managing unexpected treatment complications.
Case reports are essential in cancer research, providing in-depth analysis of uncommon or exceptional cases of cancer diagnosis, treatment, and progression. They offer unique insights that can inspire new treatment protocols, diagnostic techniques, and a better understanding of the disease’s behavior. By highlighting individual patient experiences, case reports help identify rare responses to therapies, unexpected side effects, or emerging patterns that might not be captured in large-scale studies. These reports are particularly valuable in oncology, as they enrich the scientific community’s knowledge and pave the way for future research and innovations in cancer care.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China